Novel product, method and intermediates for the preparation of azetidine derivatives

Details for Australian Patent Application No. 2005293454 (hide)

Owner Aventis Pharma S.A.

Inventors Rieke-Zapp, Joerg; Grondard, Luc; Mutti, Stephane; Crocq, Veronique; Malpart, Joel; Lavigne, Michel

Agent A J Park

Pub. Number AU-A-2005293454

PCT Pub. Number WO2006/040465

Priority 0410844 14.10.04 FR

Filing date 10 October 2005

Wipo publication date 20 April 2006

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/040465 Priority application(s): WO2006/040465

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005293460-Producing hydrogen by heterologous expression of a type ll NAD (P) H dehydrogenase in chlamydomonas

2005293453-Method and intermediates for the preparation of derivatives of N- (1-benzhydryl-azetidin-3-yl)-N-phenyl-m ethylsulphonamide